MeSH term
Frequency | Condition_Probility | Adult | 20 | 0.0 |
Aged | 8 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Animals | 11 | 0.0 |
Child | 14 | 0.0 |
Classic Migraine/diagnosis/*genetics | 2 | 100.0 |
DNA Mutational Analysis | 12 | 0.0 |
Family Health | 6 | 0.0 |
Female | 31 | 0.0 |
Genetic Markers | 3 | 0.0 |
Humans | 58 | 0.0 |
Linkage (Genetics) | 7 | 0.0 |
Lod Score | 8 | 0.0 |
Male | 35 | 0.0 |
Middle Aged | 14 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
*Mutation | 6 | 0.0 |
Na(+)-K(+)-Exchanging ATPase/*genetics | 3 | 6.0 |
Pedigree | 24 | 0.0 |
Phenotype | 11 | 0.0 |
Research Support, Non-U.S. Gov't | 35 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Temperature | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Chromosomes, Human, Pair 19/*genetics | 4 | 4.0 |
Exons/*genetics | 2 | 0.0 |
Genetic Screening | 6 | 0.0 |
Point Mutation/*genetics | 2 | 0.0 |
*Alleles | 2 | 0.0 |
Calcium Channels/*genetics | 28 | 35.0 |
Epilepsy, Generalized/*genetics | 3 | 10.0 |
Gene Frequency | 2 | 0.0 |
Genotype | 6 | 0.0 |
*Polymorphism, Genetic | 2 | 0.0 |
Protein Subunits | 2 | 0.0 |
Cluster Headache/*genetics | 2 | 66.0 |
Haplotypes | 5 | 0.0 |
Microsatellite Repeats | 6 | 0.0 |
Polymorphism, Single-Stranded Conformational | 7 | 0.0 |
Polymorphism, Genetic | 6 | 0.0 |
Cerebellum/pathology | 2 | 6.0 |
Magnetic Resonance Imaging | 3 | 0.0 |
Migraine/*complications/*genetics | 2 | 100.0 |
Point Mutation | 3 | 0.0 |
Polymorphism, Single Nucleotide | 2 | 0.0 |
Alleles | 3 | 0.0 |
Chromosomes, Human, Pair 19/genetics | 3 | 2.0 |
DNA/chemistry/genetics | 2 | 0.0 |
Migraine/*genetics | 6 | 46.0 |
Trinucleotide Repeats/genetics | 2 | 3.0 |
Cell Line | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Electrophysiology | 2 | 0.0 |
Exons | 5 | 0.0 |
Kinetics | 2 | 0.0 |
Mice | 5 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Rats | 4 | 0.0 |
Transfection | 3 | 0.0 |
Mutation, Missense/*genetics | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Gene Expression | 2 | 0.0 |
Genes, Dominant | 3 | 0.0 |
Patch-Clamp Techniques | 3 | 0.0 |
Chromosomes, Human, Pair 19 | 4 | 2.0 |
Adolescent | 13 | 0.0 |
Age of Onset | 4 | 0.0 |
*Mutation, Missense | 4 | 0.0 |
Nystagmus, Pathologic/etiology | 2 | 66.0 |
Acetazolamide/therapeutic use | 2 | 66.0 |
Anticonvulsants/therapeutic use | 2 | 8.0 |
Calcium Channels/genetics | 5 | 18.0 |
Diagnosis, Differential | 2 | 0.0 |
Calcium Channels/genetics/*metabolism | 2 | 10.0 |
Cells, Cultured | 2 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
English Abstract | 6 | 0.0 |
Migraine/genetics | 2 | 66.0 |
Classic Migraine/*genetics | 4 | 50.0 |
Common Migraine/*genetics | 2 | 40.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Calcium Channels/chemistry/*genetics/physiology | 2 | 66.0 |
Chromosome Mapping | 7 | 0.0 |
*Chromosomes, Human, Pair 19 | 3 | 0.0 |
Models, Molecular | 2 | 0.0 |
Cerebellar Ataxia/*genetics | 4 | 26.0 |
Family | 2 | 0.0 |
Prevalence | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Calcium Channels/chemistry/*genetics | 2 | 40.0 |
Protein Conformation | 2 | 0.0 |
Ataxia/*genetics | 2 | 13.0 |
Migraine/complications/*genetics | 3 | 60.0 |
Mutation | 5 | 0.0 |
Mutation, Missense | 4 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Spinocerebellar Ataxias/*genetics | 2 | 10.0 |
Models, Genetic | 2 | 0.0 |
Child, Preschool | 6 | 0.0 |
Comparative Study | 3 | 0.0 |
Brain/pathology | 2 | 0.0 |
Mutation/genetics | 2 | 0.0 |
Recurrence | 2 | 0.0 |
Trinucleotide Repeats | 2 | 1.0 |
Mutation/*genetics | 2 | 0.0 |
Classic Migraine/genetics | 2 | 50.0 |
Risk Factors | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
Linkage (Genetics)/*genetics | 2 | 0.0 |
